Aprea Therapeutics
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical...
Aprea Therapeutics Logo
About Aprea Therapeutics
Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Aprea Therapeutics serves customers in the United States and Sweden.
Address
3805 Old Easton Road,
Doylestown, 18902
United States
Year founded
2019
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
